Skip to main content
. Author manuscript; available in PMC: 2021 Jun 4.
Published in final edited form as: Nat Protoc. 2021 Apr 28;16(5):2633–2666. doi: 10.1038/s41596-021-00516-2

Table 2 |.

uliCUT&RUN sample sequencing statistics

Sample name Target Total reads mm10 mapped reads % Reads mm10 mapped sacCer3 mapped reads % Reads SacCer3 mapped
NoAb_500,000cells No-antibody control 12,519,390 7,724,115 61.69721528 4,386 0.035033656
NoAb_50,000cells No-antibody control 21,124,738 13,619,070 64.46976999 18,632 0.08819991
NoAb_5,000cells No-antibody control 22,840,561 13,639,479 59.716042 111,161 0.486682442
NoAb_500cells No-antibody control 6,721,902 2,738,302 40.73701164 88,437 1.315654409
NoAb_50cells No-antibody control 31,441,140 9,944,171 31.62789581 348,488 1.108382202
NoAb_10cells No-antibody control 22,386,707 1,528,715 6.828672926 109,941 0.491099473
CTCF_500,000cells CTCF 24,622,812 16,910,022 68.67624218 3,001 0.012187885
CTCF_50,000cells CTCF 28,244,629 19,181,790 67.91305349 9,666 0.034222436
CTCF_5,000cells CTCF 86,425,016 55,116,921 63.77426763 158,771 0.183709541
CTCF_500cells CTCF 16,011,197 7,590,239 47.40581857 51,441 0.321281413
CTCF_50cells CTCF 33,064,993 18,592,267 56.22945996 153,859 0.465322947
CTCF_10cells CTCF 52,838,179 12,155,437 23.00502635 219,423 0.415273585
NoAb_50cells No-antibody control 26,177,953 3,759,352 14.36075616 186,217 0.711350501
Sox2_50cells Sox2 37,306,970 3,788,443 10.15478608 140,045 0.375385618
Nanog_50cells Nanog 11,878,529 4,291,975 36.13220963 58,996 0.496660823
Oct4_50cells Oct4 54,221,820 5,211,784 9.611968023 169,106 0.311878133
NoAb_1cell_rep1 No-antibody control 23,265,110 74,478 0.320127435 51,691 0.222182487
NoAb_1cell_rep2 No-antibody control 27,236,861 97,674 0.358609606 67,396 0.24744408
NoAb_1cell_rep3 No-antibody control 21,219,173 50,829 0.239542795 43,526 0.205125808
NoAb_1cell_rep4 No-antibody control 21,366,345 226,075 1.058089252 54,499 0.255069363
NoAb_1cell_rep5 No-antibody control 64,767,963 196,799 0.303852385 134,532 0.207713804
CTCF_1cell_rep1 CTCF 8,058,422 33,946 0.421248726 3,158 0.039188814
CTCF_1cell_rep2 CTCF 29,785,051 117,613 0.394872582 71,249 0.239210603
CTCF_1cell_rep3 CTCF 39,235,948 157,304 0.400918056 94,497 0.240842913
CTCF_1cell_rep4 CTCF 25,623,725 167,324 0.653004198 63,394 0.247403529
CTCF_1cell_rep5 CTCF 27,905,711 97,412 0.349075499 53,672 0.19233339
blast_NoAb_rep1 No-antibody control 48,402,426 134,232 0.277324942 391,250 0.808327252
blast_NoAb_rep2 No-antibody control 10,924,378 261,010 2.38924358 130,484 1.194429559
blast_CTCF_rep1 CTCF 74,269,402 556,739 0.749620954 770,472 1.037401648
blast_CTCF_rep2 CTCF 81,540,028 468,019 0.573974539 111,8201 1.371352239

Sample name: the name of the sample that describes the target, the number of cells (1–500,000), or if a blastocyst (blast) was assayed, and the replicate number, if applicable. Target: identity of the targeted chromatin-associated protein Total reads: the total raw sequencing reads for that sample mm10 mapped reads: the number of reads mapped to mm10 reference genome % Reads mm10 mapped: the percentage of total raw reads mapped to the mm10 reference genome sacCer3 mapped reads: the number of reads mapped to sacCer3 reference genome % sacCer3 mapped: the percentage of total raw reads mapped to sacCer3 reference genome